OPOS: The Impact of Obesity on Postoperative Outcomes Following Cardiac Surgery

Sponsor
Cardiovascular Research New Brunswick (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03248921
Collaborator
Horizon Health Network (Other), Maritime Heart Centre (Other)
610
1
192
3.2

Study Details

Study Description

Brief Summary

The purpose of this study is to identify measures of obesity, functional capacity, and specific biomarkers that may be predictive of obesity and post-operative outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: cardiac surgery

Detailed Description

Background: Increasing levels of obesity worldwide have led to a rise in the prevalence of obesity-related complications including cardiovascular disease, diabetes, cancers etc. Health care providers believe that obesity has a negative effect on patients undergoing cardiac surgery, with overweight and obese patients being more likely to experience adverse post-operative outcomes. The body mass index (BMI) is the single most used measure for determining obesity classification in clinical practice, without accounting for a patient's level of cardiopulmonary fitness or muscle mass.

Study Design: Patients between the ages of 18 and 75 years undergoing elective cardiac surgery will be consented to participate in this prospective observational trial. Patients are invited to participate in measures of obesity, functional capacity and exercise capacity assessments, quality of life questionnaires, and blood and tissue sampling for biomarker analysis.

Endpoints: Measures other than BMI that could be predictive of short-term and long-term post-operative outcomes. Outcomes of interest include: prolonged length of ventilation, hospital length of stay and all-cause mortality.

Summary: The results of this trial will potentially identify an improved definition of fitness capacity for obese cardiac surgical patients and biomarkers alone or in combination that could identify the potential for adverse outcomes in patients undergoing cardiac surgery. This study will help clinicians better segregate and treat patients pre-operatively based on fitness levels and associated biomarkers.

Study Design

Study Type:
Observational
Anticipated Enrollment :
610 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Impact of Obesity on Postoperative Outcomes Following Cardiac Surgery
Actual Study Start Date :
Nov 1, 2014
Anticipated Primary Completion Date :
Nov 1, 2025
Anticipated Study Completion Date :
Nov 1, 2030

Arms and Interventions

Arm Intervention/Treatment
High-Fit obese

Cardiac surgery patients will be segregated into the high-fit group based on 6 minute walk test distance and other measures of functional capacity

Procedure: cardiac surgery
cardiac surgery including non-emergency, elective coronary artery bypass grafting surgery with or without valve surgery, aortic or mitral valve surgery

Low-Fit obese

Cardiac surgery patients will be segregated into the low-fit group based on 6 minute walk test distance and other measures of functional capacity

Procedure: cardiac surgery
cardiac surgery including non-emergency, elective coronary artery bypass grafting surgery with or without valve surgery, aortic or mitral valve surgery

Outcome Measures

Primary Outcome Measures

  1. Prolonged Hospitalization [post-operative day (POD) 30]

    A length of stay of more than 5 days

  2. Prolonged ventilation > 24 hours [post-operative day (POD) 30]

    mechanical ventilation for more than 24 hours of invasive (via endotracheal tube or tracheostomy) and/or noninvasive (facial/nasal interface) methods of delivery

Secondary Outcome Measures

  1. all cause mortality [post-operative day (POD) 30 and 1 year post-op]

    Patient death, either in hospital or long-term

  2. non fatal myocardial infarction [post-operative day (POD) 30 and 1 year post-op]

    Transmural, Subendocardial infarction

  3. Stroke [post-operative day (POD) 30]

    Transient, permanent

  4. Respiratory complications [post-operative day (POD) 30]

    Pleural effusion, pneumonia

  5. Prolonged ICU length of stay [post-operative day (POD) 30]

    length of stay of more than 48 hours

  6. Re-operation for any cause [post-operative day (POD) 30 and 1 year post-op]

    re-operation due to complications, bleeding and/or other reasons

  7. Atrial fibrillation [post-operative day (POD) 30 and 1 year post-op]

    post-op occurrence requiring treatment

  8. Post-operative length of stay and disposition on discharge [post-operative day (POD) 30 and 1 year post-op]

    home, home with care, transfer to other facility, or expired

  9. Wound infection [post-operative day (POD) 30]

    infection of sternum or other incisional access sites

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • · Provide informed consent

  • Male or female patients who are > 18 years of age

  • Patients must be scheduled to undergo elective, first-time cardiac surgery during routine scheduling times

Exclusion Criteria:
  • Patients who are > 75 years of age

  • BMI is less than 18.5 kg/m2 and classified as underweight according to the World Health Organization

  • Any non-elective first time cardiac surgery patient (eg. in-house urgent patients; emergent patients)

  • Any cardiac patients to undergo re-operation

  • Simultaneous participation in another study with an investigational study agent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Saint John Regional Hospital Saint John New Brunswick Canada E2L 4L2

Sponsors and Collaborators

  • Cardiovascular Research New Brunswick
  • Horizon Health Network
  • Maritime Heart Centre

Investigators

  • Principal Investigator: Ansar Hassan, MD, PhD, New Brunswick Heart Centre, Department of Cardiac Surgery

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Ansar Hassan, MD, PhD, Principal Investigator, Dalhousie University
ClinicalTrials.gov Identifier:
NCT03248921
Other Study ID Numbers:
  • RS#: 2014-2006
First Posted:
Aug 15, 2017
Last Update Posted:
Jul 28, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 28, 2021